2′-Deoxy-2′-α-fluoro-2′-β-C-methyl 3′,5′-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: Discovery of PSI-352938

被引：47

作者：

Reddy, P. Ganapati ^{[1
]}

Bao, Donghui ^{[1
]}

Chang, Wonsuk ^{[1
]}

Chun, Byoung-Kwon ^{[1
]}

Du, Jinfa ^{[1
]}

Nagarathnam, Dhanapalan ^{[1
]}

Rachakonda, Suguna ^{[1
]}

Ross, Bruce S. ^{[1
]}

Zhang, Hai-Ren ^{[1
]}

Bansal, Shalini ^{[1
]}

Espiritu, Christine L. ^{[1
]}

Keilman, Meg ^{[1
]}

Lam, Angela M. ^{[1
]}

Niu, Congrong ^{[1
]}

Steuer, Holly Micolochick ^{[1
]}

Furman, Phillip A. ^{[1
]}

Otto, Michael J. ^{[1
]}

Sofia, Michael J. ^{[1
]}

机构：

[1] Pharmasset Inc, Princeton, NJ 08540 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 24期

关键词：

Antiviral; HCV; Nucleoside; Prodrug; Cyclic Phosphate; C VIRUS-REPLICATION; ANTIVIRAL ACTIVITY; HUH-7; CELLS; EFFICIENT; REPLICON; RING; MONOPHOSPHATE; DESIGN;

D O I：

10.1016/j.bmcl.2010.10.035

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of novel 2'-deoxy-2'-alpha-fluoro-2'-beta-C-methyl 3',5'-cyclic phosphate nucleotide prodrug analogs were synthesized and evaluated for their in vitro anti-HCV activity and safety. These prodrugs demonstrated a 10-100-fold greater potency than the parent nucleoside in a cell-based replicon assay due to higher cellular triphosphate levels. Our structure-activity relationship (SAR) studies provided compounds that gave high levels of active triphosphate in rat liver when administered orally to rats. These studies ultimately led to the selection of the clinical development candidate 24a (PSI-352938). (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：7376 / 7380

页数：5

共 50 条

[21] Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors
Stammers, Timothy A.
Coulombe, Rene
Rancourt, Jean
Thavonekham, Bounkham
Fazal, Gulrez
Goulet, Sylvie
Jakalian, Araz
Wernic, Dominic
Tsantrizos, Youla
Poupart, Marc-Andre
Boes, Michael
McKercher, Ginette
Thauvette, Louise
Kukolj, George
Beaulieu, Pierre L.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (09) : 2585 - 2589
[22] I. Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles
Anilkumar, Gopinadhan N.
Lesburg, Charles A.
Selyutin, Oleg
Rosenblum, Stuart B.
Zeng, Qingbei
Jiang, Yueheng
Chan, Tin-Yau
Pu, Haiyan
Vaccaro, Henry
Wang, Li
Bennett, Frank
Chen, Kevin X.
Duca, Jose
Gavalas, Stephen
Huang, Yuhua
Pinto, Patrick
Sannigrahi, Mousumi
Velazquez, Francisco
Venkatraman, Srikanth
Vibulbhan, Bancha
Agrawal, Sony
Butkiewicz, Nancy
Feld, Boris
Ferrari, Eric
He, Zhiqing
Jiang, Chuan-kui
Palermo, Robert E.
Mcmonagle, Patricia
Huang, H. -C.
Shih, Neng-Yang
Njoroge, George
Kozlowski, Joseph A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (18) : 5336 - 5341
[23] Synthesis and antiviral activity of 2′-deoxy-2′-fluoro-2′-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5′-triphosphates
Shi, Junxing
Zhou, Longhu
Zhang, Hongwang
McBrayer, Tamara R.
Detorio, Mervi A.
Johns, Melissa
Bassit, Leda
Powdrill, Megan H.
Whitaker, Tony
Coats, Steven J.
Goette, Matthias
Schinazi, Raymond F.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (23) : 7094 - 7098
[24] C-13 NMR-SPECTRUM OF 2'-FLUORO-2'-DEOXYADENOSINE 3',5'-CYCLIC PHOSPHATE
UESUGI, S
MATSUGI, J
KANEYASU, T
IKEHARA, M
HETEROCYCLES, 1982, 17 : 285 - 288
[25] Synthesis of 3',5'-Cyclic Phosphate and Thiophosphate Esters of 2'-C-Methyl Ribonucleosides
Leisvuori, Anna
Ahmed, Zafar
Ora, Mikko
Beigelman, Leonid
Blatt, Lawrence
Lonnberg, Harri
HELVETICA CHIMICA ACTA, 2012, 95 (09) : 1512 - 1520
[26] Synthesis of 2′-O,4′-C-alkylene-bridged ribonucleosides and their evaluation as inhibitors of HCV NS5B polymerase
Chapron, Christopher
Glen, Rebecca
La Colla, Massimiliano
Mayes, Benjamin A.
McCarville, Joseph F.
Moore, Stephen
Moussa, Adel
Sarkar, Ruhul
Seifer, Maria
Serra, Ilaria
Stewart, Alistair
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (12) : 2699 - 2702
[27] 5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase
Ruebsam, Frank
Tran, Chinh V.
Li, Lian-Sheng
Kim, Sun Hee
Xiang, Alan X.
Zhou, Yuefen
Blazel, Julie K.
Sun, Zhongxiang
Dragovich, Peter S.
Zhao, Jingjing
McGuire, Helen M.
Murphy, Douglas E.
Tran, Martin T.
Stankovic, Nebojsa
Ellis, David A.
Gobbi, Alberto
Showalter, Richard E.
Webber, Stephen E.
Shah, Amit M.
Tsan, Mei
Patel, Rupal A.
LeBrun, Laurie A.
Hou, Huiying J.
Kamran, Ruhi
Sergeeva, Maria V.
Bartkowski, Darian M.
Nolan, Thomas G.
Norris, Daniel A.
Kirkovsky, Leo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (02) : 451 - 458
[28] 2-Aryl-3-carbonylquinolones: Design, Synthesis and Biological Evaluation of Novel HCV NS5B Polymerase Inhibitors
Wang Shenfeng
Lin Jianping
He Peilan
Zuo Jianping
Long Yaqiu
ACTA CHIMICA SINICA, 2014, 72 (08) : 906 - 913
[29] MEDI 330-Beta-D-2'-Deoxy-2'-fluoro-2'-C-methyluridine (PSI-6206) phosphoramidates: Potent liver targeting nucleoside inhibitors of HCV RNA replication
Sofia, Michael J.
Wang, Peiyuan
Du, Jinfa
Steuer, Holly Micolochick
Niu, Congrong
Ross, Bruce S.
Rachakonda, Suguna
Furman, Phillip A.
Otto, Michael J.
Nagarathnam, Dhanapalan
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
[30] Synthesis and evaluation of novel phosphoramidate prodrugs of 2′-methyl cytidine as inhibitors of hepatitis c virus NS5B polymerase
Donghi, Monica
Attenni, Barbara
Gardelli, Cristina
Di Marco, Annalise
Fiore, Fabrizio
Giuliano, Claudio
Laufer, Ralph
Leone, Joseph F.
Pucci, Vincenzo
Rowley, Michael
Narjes, Frank
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (05) : 1392 - 1395

← 1 2 3 4 5 →